R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

From Covid to cancer: Moderna’s new challenge

In the autumn of 2021, I had the pleasure and misfortune of presenting at a conference straight after Moderna chief executive Stéphane Bancel.

R&D

ASCO 2023 preview: Prioritising the exploration of patient d...

The American Society of Clinical Oncology (ASCO) annual meeting is approaching and provides the ideal setting to connect

R&D

London, ABPI annual conference, part three

Delivery crucial for UK clinical trials improvement - ABPI a...

The UK Life Sciences Council, a twice-yearly meeting between ministers and global life sciences industry leaders, met on Thursday 25th May to discuss the sector’s economic

R&D

Health Innovators – Jennifer Schranz

In the rare and ultra-rare disease space, the paucity of both data and patients makes everything about research and development more complicated.

R&D

How breath analysis could help those living with gut health ...

It has been estimated that 12% of the UK population suffer from irritable bowel syndrome (IBS), an umbrella term that describes a bro

R&D

Making babies healthier with a ‘lost bacterium’

At the World Without Disease Summit next month, Infinant Health CEO Mike Johnson will discuss his company’s unique insights into the infant microbiome.